Advanced search
Publication Cover
Expert Opinion on Pharmacotherapy Volume 10, 2009 - Issue 10
Submit an article Journal homepage
325
Views
16
CrossRef citations to date
0
Altmetric
Original Research

A randomized, comparative study evaluating the efficacy and tolerability of losartan-low dose chlorthalidone (6.25 mg) combination with losartan-hydrochlorothiazide (12.5 mg) combination in Indian patients with mild-to-moderate essential hypertension

Anil Pareek President Medical Affairs and Clinical Research, Ipca Laboratories Ltd, 142 AB, Kandivli Industrial Estate, Kandivli (West), Mumbai 400067, India +91 22 66474747; +91 22 28686954; [email protected]
,
Hathur Basavanagowdappa Professor and Head JSS Medical College, Department of Medicine, Mysore, India
,
Shyamsundar Zawar Associate Professor Indira Gandhi Government Medical College, Department of Medicine, Nagpur, India
,
Anil Kumar Associate Professor MS Ramaiah Medical College, Department of Medicine, Bangalore, India
&
Nitin Chandurkar Assistant General Manager Clinical Research and Development, Ipca Laboratories Ltd, Mumbai, India
Pages 1529-1536 | Published online: 11 Jun 2009

Citations (16)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (3)

L.E.J. Peeters, M.P. Kester, L. Feyz, P.M.L.A. Van Den Bemt, B.C.P. Koch, T. Van Gelder & J. Versmissen. (2019) Pharmacokinetic and pharmacodynamic considerations in the treatment of the elderly patient with hypertension. Expert Opinion on Drug Metabolism & Toxicology 15:4, pages 287-297.
Read now
Masanori Abe, Kazuyoshi Okada & Koichi Matsumoto. (2009) Clinical experience in treating hypertension with fixed-dose combination therapy: angiotensin II receptor blocker losartan plus hydrochlorothiazide. Expert Opinion on Drug Metabolism & Toxicology 5:10, pages 1285-1303.
Read now
Domenic A Sica. (2009) Chlorthalidone – a renaissance in use?. Expert Opinion on Pharmacotherapy 10:13, pages 2037-2039.
Read now

Articles from other publishers (13)

Eun Joo Cho, Moo Hyun Kim, Young‐Hak Kim, Kiyuk Chang, Dong‐Ju Choi, Woong Chol Kang, Jinho Shin, Seong Hwan Kim, Namho Lee, Jang Won Son, Joon‐Hyung Doh, Woo‐Shik Kim, Soon Jun Hong, Moo‐Yong Rhee, Youngkeun Ahn, Sang‐Wook Lim, Seung Pyo Hong, So‐Yeon Choi, Min Su Hyon, Jin‐Yong Hwang, Kihwan Kwon, Kwang Soo Cha, Sang‐Hyun Ihm, Jae‐Hwan Lee, Byung‐Su Yoo & Hyo‐Soo Kim. (2023) Efficacy and safety of standard dose triple combination of telmisartan 80 mg/amlodipine 5 mg/chlorthalidone 25 mg in primary hypertension: A randomized, double‐blind, active‐controlled, multicenter phase 3 trial. The Journal of Clinical Hypertension 25:9, pages 817-827.
Crossref
Raja Ram Khenhrani, Ijeoma Nnodebe, Anurag Rawat, Rahul Adwani, Ammara Ghaffar, Sapna Devi, Muhammad Sohaib Afzal & Muhammad Usama. (2023) Comparison of the Effectiveness and Safety of Chlorthalidone and Hydrochlorothiazide in Patients With Hypertension: A Meta-Analysis. Cureus.
Crossref
George C. Roush & Franz H. Messerli. (2021) Chlorthalidone versus hydrochlorothiazide: major cardiovascular events, blood pressure, left ventricular mass, and adverse effects. Journal of Hypertension 39:6, pages 1254-1260.
Crossref
Nicholas D. Fried, Tamara M. Morris, Anna Whitehead, Eric Lazartigues, Xinping Yue & Jason D. Gardner. (2021) Angiotensin II type 1 receptor mediates pulmonary hypertension and right ventricular remodeling induced by inhaled nicotine. American Journal of Physiology-Heart and Circulatory Physiology 320:4, pages H1526-H1534.
Crossref
Stela Dineva, Katya Uzunova, Velichka Pavlova, Elena Filipova, Krassimir Kalinov & Toni Vekov. (2020) Network meta-analysis of efficacy and safety of chlorthalidone and hydrochlorothiazide in hypertensive patients. Blood Pressure Monitoring 26:2, pages 160-168.
Crossref
Anil Pareek, C Venkata S Ram, Ravi T Mehta & Shruti Dharmadhikari. (2020) Optimising TRIUMPH with 6·25 mg chlorthalidone. The Lancet Global Health 8:2, pages e175.
Crossref
Stela Dineva, Katya Uzunova, Velichka Pavlova, Elena Filipova, Krassimir Kalinov & Toni Vekov. (2019) Comparative efficacy and safety of chlorthalidone and hydrochlorothiazide—meta-analysis. Journal of Human Hypertension 33:11, pages 766-774.
Crossref
Ravi Tejraj Mehta, Anil Pareek & Indranil Purkait. (2018) Chlorthalidone, not hydrochlorothiazide, is the right diuretic for comparison. Clinical Hypertension 24:1.
Crossref
Wenjing Liang, Hui Ma, Luxi Cao, Wenjiang Yan & Jingjing Yang. (2017) Comparison of thiazide-like diuretics versus thiazide-type diuretics: a meta-analysis . Journal of Cellular and Molecular Medicine 21:11, pages 2634-2642.
Crossref
Anil K. Pareek, Franz H. Messerli, Nitin B. Chandurkar, Shruti K. Dharmadhikari, Anil V. Godbole, Prasita P. Kshirsagar, Manish A. Agarwal, Kamal H. Sharma, Shyam L. Mathur & Mukund M. Kumbla. (2016) Efficacy of Low-Dose Chlorthalidone and Hydrochlorothiazide as Assessed by 24-h Ambulatory Blood Pressure Monitoring. Journal of the American College of Cardiology 67:4, pages 379-389.
Crossref
George C. RoushMichael E. ErnstJohn B. KostisSuraj TandonDomenic A. Sica. (2015) Head-to-Head Comparisons of Hydrochlorothiazide With Indapamide and Chlorthalidone. Hypertension 65:5, pages 1041-1046.
Crossref
George C. Roush, Michael E. Ernst, John B. Kostis, Ramandeep Kaur & Domenic A. Sica. (2015) Not Just Chlorthalidone: Evidence-Based, Single Tablet, Diuretic Alternatives to Hydrochlorothiazide for Hypertension. Current Hypertension Reports 17:4.
Crossref
Weberton Reis do Carmo, Fabio Furlan Ferreira & Renata Diniz. (2014) Phase quantification of antihypertensive drugs – Chlorthalidone, Hydrochlorothiazide, Losartan and combinations, Losartan/Chlorthalidone and Losartan/Hydrochlorothiazide – by the Rietveld method. Journal of Pharmaceutical and Biomedical Analysis 88, pages 152-156.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.